Financials

News Ideas Technicals

4111 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to CHI SHENG PHARMA & BIOTECH CO LTD operating, investing, and financing activities

4111 free cash flow for Q1 24 is -738 k TWD. For 2023, 4111 free cash flow was -32.77 M TWD and operating cash flow was 68.73 M TWD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—